History
2024: Investing 600 million rubles in the production of medical equipment
The company "DEACON-DS," engaged in the production of equipment for Invitro, plans to expand the production of medical equipment for research. To do this, the company invests 600 million rubles in the creation of a modern high-tech production complex. This was reported to Vedomosti in March 2024.
According to the Ministry of Investment, Industry and Science of the Moscow Region, for the implementation of the project, the company was provided with a plot under the Earth for 1 ruble program in the urban district of Pushchino.
 | The volume of investments of DEACON-DS in the construction and launch of a modern production complex equipped with high-tech equipment will amount to about 600 million rubles. At the new enterprise, it is planned to create about 20 jobs for residents of the Moscow region. The investor plans to complete the construction and launch new production in the IV quarter of 2026, said Ekaterina Zinovieva, Minister of Investments, Industry and Science of the Moscow Region. |  |
Deacon-DS has been producing equipment and components for medical research for more than 25 years. To date, 130 reagents are produced at the company's enterprises in the Moscow Region to determine 50 indicators in human biological fluids. According to research agencies, more than 20% of biochemical research is due to the company's reagents.
The launch of the new complex will speed up import substitution of products for the diagnosis of diabetes mellitus, cancer and diseases of the cardiovascular system.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |